![Luis Maranga](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luis Maranga served as the General Manager-Devens Biologics Operations at Bristol Myers Squibb Co. from 2015 to 2017.
Prior to that, he was the Head-Technical Development & Viral Vaccines at Novartis Vaccines & Diagnostics, Inc. and the Chief Technical Operations Officer at Voyager Therapeutics, Inc. Dr. Maranga holds a doctorate degree from Universidade Nova de Lisboa and an undergraduate degree from Instituto Superior Técnico de Lisboa.
| Unternehmen | Position | Ende |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | - |
| VOYAGER THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Universidade Nova de Lisboa
 Universidade Nova de Lisboa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instituto Superior Técnico de Lisboa
 Instituto Superior Técnico de Lisboa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
